Cara Sholter, MBA

Vice President Of Quality

Professional Overview:
Cara Sholter is a seasoned quality assurance executive with extensive experience in the pharmaceutical and biotechnology industries. As the Vice President of Quality at Immunomic Therapeutics, Inc., she leads a team responsible for ensuring the highest standards of product quality and regulatory compliance.

Experience Summary:

Current Role:
In her current position, Cara oversees all aspects of quality management, including quality control, quality assurance, and validation processes. She plays a pivotal role in driving continuous improvements, implementing robust quality systems, and fostering a culture of quality. Under her leadership, Immunomic Therapeutics has successfully navigated complex regulatory environments and maintained a flawless quality record.

Career Progression:
Prior to her current role, Cara served as the Director of Quality at Immunomic Therapeutics, where she was instrumental in streamlining quality control processes and enhancing cross-functional collaboration. She also held the position of Deputy Director of Quality Compliance at MedImmune LLC, where she demonstrated her expertise in navigating regulatory requirements and maintaining compliance with industry standards.

Academic Background:
Cara holds a Master of Business Administration (MBA) degree, which has equipped her with a strong foundation in strategic management, financial analysis, and decision-making. Her academic achievements, combined with her extensive industry experience, have made her a respected leader in the field of quality assurance.

Areas of Expertise:

• Quality management and quality control

• Regulatory compliance and auditing

• Pharmaceutical and biotechnology industry knowledge

• Process improvement and optimization

• Cross-functional collaboration and team leadership

Professional Impact:
Cara has played a pivotal role in driving quality excellence across the organizations she has served. Her leadership has been instrumental in maintaining flawless quality records, ensuring regulatory compliance, and fostering a culture of continuous improvement. Cara's contributions have directly contributed to the success and growth of the companies she has been a part of.

Conclusion:
With her exceptional quality management expertise, strong leadership skills, and deep industry knowledge, Cara Sholter is a valuable asset to Immunomic Therapeutics, Inc. Her commitment to quality and her proven track record of driving successful quality initiatives make her a respected professional in the pharmaceutical and biotechnology sectors.